We serve ethyl 4-chlorobutanoate CAS:3153-36-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: ethyl 4-chlorobutanoate
CAS.NO: 3153-36-4
Synonyms:
ethyl 4-chlorobutyrate
4-chloro-butyric acid ethyl ester
Butanoic acid, 4-chloro-, ethyl ester;
Ethyl 4-chlorobutanoate
4-Chlorobutyric Acid Ethyl Ester
Butyric acid,4-chloro-,ethyl ester
4-chlorobutanoic acid ethyl ester
Ethyl |A-Chlorobutyrate
Butanoic acid,4-chloro-,ethyl ester
4-chloro-3-oxobutyric acid ethyl ester
Molecular Formula: C6H11ClO2
Molecular Weight: 150.60300
Physical and Chemical Properties:
Density: 1.075 g / mL at 25 ° C (lit.)
Boiling point: 186 ° C (lit.)
Melting point: -70ºC
Flash point: 125 ° F
Refractive index: n20 / D 1.432 (lit.)
Specification:
Appearance:Clear yellow to brownish liquid
Purity:≥98.0%
Moisture Content: ≤0.2%
Impurity: ≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep away from heat, sparks, and flame. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like ethyl 4-chlorobutanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-3-oxobutyric acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-butyric acid ethyl ester Use and application,4-chloro-butyric acid ethyl ester technical grade,usp/ep/jp grade.
Related News: This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.1-Chlorododecane manufacturer Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine supplier Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.4-Chlorobenzaldehyde vendor “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”
